跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/ VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/ VIAL
Approved
THERAPEUTIC
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/ VIAL
MEFAR ILAC SANAYII A.S. - TURKEYELPEN PHARMACEUTICAL CO., INC (GREECE)
🇸🇬 Health Sciences Authority
Approval Date
Sep 28, 2018
Approval ID
263f864581623401
Company
MEFAR ILAC SANAYII A.S. - TURKEYELPEN PHARMACEUTICAL CO., INC (GREECE)
Type
Therapeutic
Approval Details
Approval Id
263f864581623401
Drug Name
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/ VIAL
Product Name
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/ VIAL
Approval Number
SIN15552P
Approval Date
2018-09-28
Registrant
NOVEM PHARMA PRIVATE LIMITED
Licence Holder
NOVEM PHARMA PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J02AX04
Atc Item Name
caspofungin
Pharma Manufacturer Name
LOTUS INTERNATIONAL PTE. LTD.
Company Detail Path
/organization/lotus-international-pte-ltd
Active Ingredients
Caspofungin Acetate 77.69mg/ vial eqv. Caspofungin
70.00mg/ vial
CASPOFUNGIN ACETATE 77.69 MG/VIAL EQV. CASPOFUNGIN
70 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 28, 2018
Approval ID
263f864581623401
Type
Therapeutic
Back to HSA Approvals